References
- Cassou B. Epidemiologie des maladies rheumatismales en France. Rev Medicine XXII 1981; 15: 883
- Friou G. J. The significance of the lupus globulin-nucleoprotein reaction. Ann Int Med 1958; 49: 866
- Ginsberg B., Keiser H. A Millipore filter assay for antibodies to native DNA in sera of patients with systemic lupus erythematosus. Arthritis Rheum 1973; 16: 199
- Hawkins B. R., Houliston J. B., Dawkins R. L. Distribution of HLA A, B and C antigens in an Australian population. Human Genetics 1979; 52(2)193
- Holborow E. J., Weir D. M. Further work on the antinuclear serum factor in connective tissue disease. Ann Rheum Dis 1958; 17: 122
- Karsh J., Halbert S. P., Anken M., Klima E., Steinberg A. D. Anti-DNA, anti-deoxyribonucleoprotein and rheumatoid factor measured by ELISA in patients with systemic lupus erythematosus, Sjögren's syndrome and rheumatoid arthritis. Int Arch Allergy Appl Immunol 1982; 68(1)60
- Lerner M. R., Steitz J. A. Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 1979; 76: 5495
- Milgrom F., Tonder O. Reaction between rheumatoid sera and erythrocytes sensitized with guinea pig antibody. Acta Rheum Scand 1964; 10: 177
- Minden P., Farr R. S. Handbook of Experimental Immunology, D. W. Weir. Blackwell, Oxford 1967; 463
- Nairn R. C. Fluorescent Protein Tracing, 4th edn. Churchill Livingstone. 1976; 376
- Ng K. C., Brown K. A., Perry J. D., Holborow E. J. Anti-RANA antibody: A marker for seronegative and seropositive rheumatoid arthritis. Lancet 1980; i(8166)447
- Reichlin M. Current perspectives on serological reactions in SLE patients. Clin Exp Immunol 1981; 44: 1
- Ropes M. W., Bennett G. A., Cobb S., Jacox R., Jessar R. A. 1958 Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958; 9: 175
- Sharp G. C., Irvin W. S., Tan E. M., Gould R. G., Holman H. R. Mixed connective tissue disease—an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972; 52: 48
- Tan E. M., Kunkel H. G. Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J Immunol 1966; 96: 464
- Tan E. M., Rodnan G. P. Profile of antinuclear antibodies in progressive systemic sclerosis (PSS). Arthritis Rheum 1975; 18: 430
- Tan E. M. Antinuclear antibodies: significance of biochemical specificities. Immunopathology of the Skin, E. H. Beutner, T. P. Chorzelski, S. F. Bean. Wiley, TorontoCanada 1979; 337
- Venables P. J., Erhardt C. C., Maini R. N. Antibodies to extractable nuclear antigens in rheumatoid arthritis: reltionship to vasculitis and circulating immune complexes. Clin Exp Immunol 1980; 39(1)146
- Warlow R., Carrano J., Dawkins R. A rapid screening enzyme linked immunosorbent assay for autoantibodies to extractable nuclear antigens. Diagn Immunol 1984; 2: 154
- Warlow R. S., Dawkins R. L. Subsets of autoantibodies to extractable nuclear antigens (ENA) as assayed by ELISA correlate with specific clinical abnormalities in SLE. Scand J Rheumatol, [in press]
- Warlow R. S., Garlepp M., Dawkins R. L. ENA autoantibodies in myasthenia gravis: Correlation with thymoma and other autoantibodies. J. Neuroimmunol. 1985; 8
- Wolfe J. F., Adelstein E., Sharp G. D. Antinuclear antibody with distinct specificity for polymyositis. J Clin Invest 1977; 59: 176